Propensity score-matched analysis of internal stent vs external stent for pancreatojejunostomy during pancreaticoduodenectomy: Japanese-Korean cooperative project
Manabu Kawai(Wakayama Medical University), Masakazu Yamamoto(Tokyo Women's Medical University), Sang‐Jae Park(National Cancer Center), Ki Byung Song(Ulsan College), Wataru Izumo(Yonsei University), Katsuhiko Uesaka(Shizuoka Cancer Center), Seiko Hirono(Wakayama Medical University), Ryo Ashida(National Institute of Genetics), Tae Ho Hong(The Catholic University of Korea Seoul St. Mary's Hospital), Jin Seok Heo(Seoul National University), Masayuki Sho(Nara Medical University), Tsutomu Fujii(University of Toyama), Sun‐Whe Kim(Seoul National University), Ryosuke Amano(Osaka City University), Takumi Fukumoto(Kobe University), Toshio Shimokawa(Wakayama Medical University), Song Cheol Kim(Ulsan College), Hongbeom Kim(Chonnam National University Hospital), Hiroki Yamaue(Wakayama Medical University), Sohei Satoi(Kansai Medical University), Jin‐Young Jang(Seoul National University), Dong Sup Yoon(Yonsei University), Michiaki Unno(Tohoku University), Joo Seop Kim(Hallym University), Joon Seong Park(Yonsei University), Seong Ho Choi(Busan Medical Center), Masafumi Nakamura(Shizuoka Cancer Center), Sae Byeol Choi(Korea University Medical Center), Hee Chul Yu(Tokyo Women's Medical University), Young Joon Ahn(Hallym University)
Cited by 34
Related Papers
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)
|Japanese Journal of Clinical Oncology|2018|534
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401